Drawing for YIRVADA

USPTO serial 86378261

YIRVADA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
GOLD, BARBARA
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with YIRVADA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Janet L. Cullum

Janet L. Cullum Cooley LLP1299 Pennsylvania Ave., NWSuite 700Washington, DC 20004

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery system consisting of an implantable osmotic mini-pump sold with medication used in the continuous release of a therapeutic formulation for the treatment of diabetes; Pharmaceutical preparations for the treatment of diabetesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 18, 2015MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
May 18, 2015ABN5ABANDONMENT - AFTER PUBLICATION—
May 15, 2015EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Apr 17, 2015CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 17, 2015COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 17, 2014ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 18, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 18, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 20, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 20, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 16, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 16, 2014ALIEASSIGNED TO LIE—
Sep 29, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Sep 29, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 29, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 29, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 28, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2014DOCKASSIGNED TO EXAMINER—
Sep 9, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 30, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance